| 國立臺灣大學 |
2004-11 |
Cancer-specific activation of the survivin promoter and its potential use in gene therapy.
|
Chen, Jin-Shing; Liu, Jaw-Ching. Shen, Lei. Rau, Kung-Ming. Kuo, Hsu-Ping. Li, Yan M. Shi, Daren. Lee, Yung-Chie. Chang, King-Jen. Hung, Mien-Chie. |
| 臺大學術典藏 |
2020-10-23T07:13:56Z |
Cancer-specific mortality in chronic kidney disease: Longitudinal follow-up of a large cohort
|
Weng P.-H.; Hung K.-Y.; HSIEN-LIANG HUANG; Chen J.-H.; Sung P.-K.; Huang K.-C. |
| 臺大學術典藏 |
2020-11-27T03:24:50Z |
Cancer-specific mortality in chronic kidney disease: Longitudinal follow-up of a large cohort
|
Weng P.-H.;Kuan-Yu Hung;Huang H.-L.;Chen J.-H.;Sung P.-K.;Huang K.-C.; Weng P.-H.; KUAN-YU HUNG; Huang H.-L.; Chen J.-H.; Sung P.-K.; Huang K.-C. |
| 臺大學術典藏 |
2020-11-30T07:35:52Z |
Cancer-specific mortality in chronic kidney disease: Longitudinal follow-up of a large cohort
|
Weng P.-H. ;Hung K.-Y. ;Huang H.-L. ;Jen-Hau Chen ;Sung P.-K. ;Huang K.-C.; Weng P.-H.; Hung K.-Y.; Huang H.-L.; JEN-HAU CHEN; Sung P.-K.; Huang K.-C. |
| 臺大學術典藏 |
2021-08-20T04:14:17Z |
Cancer-specific mortality in chronic kidney disease: Longitudinal follow-up of a large cohort
|
Weng P.-H.; KUAN-YU HUNG; Huang H.-L.; Chen J.-H.; Sung P.-K.; Huang K.-C. |
| 臺大學術典藏 |
2021-01-14T03:09:04Z |
Cancer-specific mortality in chronic kidney disease: Longitudinal follow-up of a large cohort
|
Weng P.-H.; Hung K.-Y.; Huang H.-L.; Chen J.-H.; Sung P.-K.; KUO-CHIN HUANG |
| 臺北醫學大學 |
2014 |
Cancer-specific Survival After Metastasis Following Primary Radical Prostatectomy Compared with Radiation Therapy in Prostate Cancer Patients: Results of a Population-based, Propensity Score-Matched Analysis
|
Shao, Yu-Hsuan Joni;Kim, Sung;Moore, Dirk F.;Shih, Weichung;Lin, Yong;Stein, Mark;Kim, Isaac Yi;Lu-Yao, Grace L. |
| 臺大學術典藏 |
2022-01-19T09:29:44Z |
Cancer-specifically re-spliced TSG101 mRNA promotes invasion and metastasis of nasopharyngeal carcinoma
|
Chua H.-H.; Kameyama T.; Mayeda A.; TE-HUEI YEH |
| 國家衛生研究院 |
2011-04 |
Cancer-targeted BikDD gene therapy elicits protective antitumor immunity against lung cancer
|
Sher, YP;Liu, SJ;Chang, CM;Lien, SP;Chen, CH;Han, ZB;Li, LY;Chen, JS;Wu, CW;Hung, MC |
| 國立臺灣大學 |
2011 |
Cancer-Targeted Bikdd Gene Therapy Elicits Protective Antitumor Immunity against Lung Cancer
|
佘玉萍; 劉士任; 張君銘; 連淑培; 李龍緣; 陳晉興; 吳成文; 洪明奇; SHER, YUH-PYNG; LIU, SHIH-JEN; CHANG, CHUN-MIEN; LIEN, SHU-PEI; LI, LONG-YUAN; CHEN, JIN-SHING; WU, CHENG-WEN; HUNG, MIEN-CHIE |
| 臺大學術典藏 |
2011 |
Cancer-targeted BikDD gene therapy elicits protective antitumor immunity against lung cancer
|
Sher Y.-P.;Liu S.-J.;Chang C.-M.;Lien S.-P.;Chen C.-H.;Han Z.;Li L.-Y.;Jin-Shing Chen;Wu C.-W.;Hung M.-C.; Sher Y.-P.; Liu S.-J.; Chang C.-M.; Lien S.-P.; Chen C.-H.; Han Z.; Li L.-Y.; JIN-SHING CHEN; Wu C.-W.; Hung M.-C. |
| 中國醫藥大學 |
2011-04 |
Cancer-targeted gene therapy elicits protective anti-tumor immunity against lung cancer metastasis. Molecular Cancer Therapeutics.
|
佘玉萍(Yuh-Pyng Sher); 劉士任(Shih-Jen Liu); (Chang CM); (Lien SP); (Chen CH); (Han Z); 李龍緣(Long-Yuan Li); (Chen JS); (Wu CW); 洪明奇(Mien-Chie Hung)* |
| 中國醫藥大學 |
2011-11-21 |
Cancer-targeted gene therapy for delivering endostatin-cytosine deaminase fusion protein with 5-fluorocytosine suppresses ovarian tumor growth.
|
佘玉萍(Yuh-Pyng Sher);(Chun-Mien Chang);(Chiun-Gung Juo);(Chun-Te Chen);林振源(Chen-Yuan Lin);(Zhenbo Han);(Shine-Gwo Shiah);洪明奇(Mien-Chie Hung)* |
| 嘉南藥理大學 |
2009 |
Cancer/Radioth�rapie
|
Elsevier SDOL |
| 國家衛生研究院 |
2014-07 |
Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression
|
Chen, JY;Li, CF;Kuo, CC;Tsai, K;Hou, MF;Hung, WC |
| 臺大學術典藏 |
2022-09-06T08:38:46Z |
Cancer: Arginine starvation impairs mitochondrial respiratory function in ASS1-deficient breast cancer cells
|
Qiu F.; Chen Y.-R.; Liu X.; Chu C.-Y.; LI-JIUAN SHEN; Xu J.; Gaur S.; Forman H.J.; Zhang H.; Zheng S.; Yen Y.; Huang J.; Kung H.-J.; Ann D.K. |
| 國立成功大學 |
1991-08-09 |
CANCERLIT資料庫簡介
|
崑巖醫學圖書分館 |
| 臺大學術典藏 |
2018-09-10T09:39:53Z |
Cancerous inhibitor of protein phosphatase 2A determines bortezomib-induced apoptosis in leukemia cells
|
HSIANG-PO HUANG; Kuen-Feng Chen |
| 臺大學術典藏 |
2021-06-03T06:50:16Z |
Cancerous inhibitor of protein phosphatase 2A determines bortezomib-induced apoptosis in leukemia cells
|
Liu C.-Y.; Shiau C.-W.; Kuo H.-Y.; HSIANG-PO HUANG; Chen M.-H.; Tzeng C.-H.; Chen K.-F. |
| 臺大學術典藏 |
2018-09-10T09:39:53Z |
Cancerous Inhibitor of Protein Phosphatase 2A Mediates Bortezomib-Induced Autophagy in Hepatocellular Carcinoma Independent of Proteasome
|
Yu, H.-C.;Hou, D.-R.;Liu, C.-Y.;Lin, C.-S.;Shiau, C.-W.;Cheng, A.-L.;Chen, K.-F.; Yu, H.-C.; Hou, D.-R.; Liu, C.-Y.; Lin, C.-S.; Shiau, C.-W.; Cheng, A.-L.; Chen, K.-F.; CHEN-SI LIN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:50Z |
Cancerous Inhibitor of Protein Phosphatase 2A Mediates Bortezomib-Induced Autophagy in Hepatocellular Carcinoma Independent of Proteasome
|
Yu H.-C.; Hou D.-R.; Liu C.-Y.; Lin C.-S.; Shiau C.-W.; ANN-LII CHENG; Chen K.-F. |
| 國家衛生研究院 |
2019-09-12 |
Cancers in Taiwan: Practical insight from epidemiology, treatments, biomarkers, and cost
|
Kuo, CN;Liao, YM;Kuo, LN;Tsai, HJ;Chang, WC;Yen, Y |
| 國立臺北護理健康大學 |
2019 |
Cancers Preceding Parkinson's Disease after Adjustment for Bias in a Danish Population-Based Case-Control Study
|
Ritz, Beate; Arah, Onyebuchi A; Lee, Pei-Chen; Hansen, Johnni; Liew, Zeyan; Cui, Xin |
| 國立臺北護理健康大學 |
2019 |
Cancers Preceding Parkinson’s Disease after Adjustment for Bias in a Danish Population-Based Case-Control Study
|
Ritz, Beate; Araha, Onyebuchi A.; Hansen, Johnni; Lee, Pei Chen; Liew, Zeyan; Cui, Xin |
| 臺大學術典藏 |
2002 |
Candida albicans Als1p: An adhesin that is a downstream effector of the EFG1 filamentation pathway
|
Fu, Y. and Ibrahim, A.S. and Sheppard, D.C. and Chen, Y.-C. and French, S.W. and Cutler, J.E. and Filler, S.G. and Edwards Jr., J.E.; YEE-CHUN CHEN |
